Attenuation of Experimental Atherosclerosis by Interleukin-19.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Attenuation of Experimental Atherosclerosis by Interleukin-19. / Ellison, Stephen; Gabunia, Khatuna; Kelemen, Sheri E; England, Ross N; Scalia, Rosario; Richards, James M; Orr, Wayne; Traylor, James G; Rogers, Thomas; Cornwell, William; Berglund, Lisa; Goncalves, Isabel; Gomez, Maria; Autieri, Michael V.

I: Arteriosclerosis, Thrombosis and Vascular Biology, Vol. 33, Nr. 10, 2013, s. 2316-2324.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

Ellison, S, Gabunia, K, Kelemen, SE, England, RN, Scalia, R, Richards, JM, Orr, W, Traylor, JG, Rogers, T, Cornwell, W, Berglund, L, Goncalves, I, Gomez, M & Autieri, MV 2013, 'Attenuation of Experimental Atherosclerosis by Interleukin-19.', Arteriosclerosis, Thrombosis and Vascular Biology, vol. 33, nr. 10, s. 2316-2324. https://doi.org/10.1161/ATVBAHA.113.301521

APA

Ellison, S., Gabunia, K., Kelemen, S. E., England, R. N., Scalia, R., Richards, J. M., ... Autieri, M. V. (2013). Attenuation of Experimental Atherosclerosis by Interleukin-19. Arteriosclerosis, Thrombosis and Vascular Biology, 33(10), 2316-2324. https://doi.org/10.1161/ATVBAHA.113.301521

CBE

Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr W, Traylor JG, Rogers T, Cornwell W, Berglund L, Goncalves I, Gomez M, Autieri MV. 2013. Attenuation of Experimental Atherosclerosis by Interleukin-19. Arteriosclerosis, Thrombosis and Vascular Biology. 33(10):2316-2324. https://doi.org/10.1161/ATVBAHA.113.301521

MLA

Vancouver

Author

Ellison, Stephen ; Gabunia, Khatuna ; Kelemen, Sheri E ; England, Ross N ; Scalia, Rosario ; Richards, James M ; Orr, Wayne ; Traylor, James G ; Rogers, Thomas ; Cornwell, William ; Berglund, Lisa ; Goncalves, Isabel ; Gomez, Maria ; Autieri, Michael V. / Attenuation of Experimental Atherosclerosis by Interleukin-19. I: Arteriosclerosis, Thrombosis and Vascular Biology. 2013 ; Vol. 33, Nr. 10. s. 2316-2324.

RIS

TY - JOUR

T1 - Attenuation of Experimental Atherosclerosis by Interleukin-19.

AU - Ellison, Stephen

AU - Gabunia, Khatuna

AU - Kelemen, Sheri E

AU - England, Ross N

AU - Scalia, Rosario

AU - Richards, James M

AU - Orr, Wayne

AU - Traylor, James G

AU - Rogers, Thomas

AU - Cornwell, William

AU - Berglund, Lisa

AU - Goncalves, Isabel

AU - Gomez, Maria

AU - Autieri, Michael V

PY - 2013

Y1 - 2013

N2 - Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not detected in normal artery and is expressed to a greater degree in plaque from symptomatic versus asymptomatic patients, suggesting a compensatory counter-regulatory function. We tested whether IL-19 could reduce atherosclerosis in susceptible mice and identified plausible mechanisms.

AB - Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not detected in normal artery and is expressed to a greater degree in plaque from symptomatic versus asymptomatic patients, suggesting a compensatory counter-regulatory function. We tested whether IL-19 could reduce atherosclerosis in susceptible mice and identified plausible mechanisms.

U2 - 10.1161/ATVBAHA.113.301521

DO - 10.1161/ATVBAHA.113.301521

M3 - Article

VL - 33

SP - 2316

EP - 2324

JO - Arteriosclerosis, Thrombosis and Vascular Biology

T2 - Arteriosclerosis, Thrombosis and Vascular Biology

JF - Arteriosclerosis, Thrombosis and Vascular Biology

SN - 1524-4636

IS - 10

ER -